SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Revolution Medicines price target raised to $265

Benzinga reported that B of A Securities raised its price target on Revolution Medicines to $265.00 per share from $225.00.

RVMD

Related stories